All News

There are some great resources out there to help educate patients and healthcare providers to combat the epidemic, according to Dr. Deutsch.

The submission is based on 2 pivotal phase 3 studies evaluating the drug in adult patients with chronic and episodic migraines.

The results showed a 38.1% confirmed objective response rate among HER2-positive patients who received tucatinib in combination with trastuzumab.

A review of decades of research concluded that there is no evidence of an association between serotonin levels and depression, calling the function of antidepressants into question.

Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.

Thera Tears helps with the symptoms of dry eyes.

The increase in gabapentin-related overdose deaths follows a rising trend in overall overdose deaths during the COVID-19 pandemic.

The FDA granted the vaccine series Emergency Use Authorization on July 14, based on clinical trial data showing significant efficacy and safety.

Poziotinib is an irreversible pan HER2 inhibitor with activity against mutations of HER1, HER2, and HER4.

It's really been a challenge for Health Mart pharmacies with the labor market the way that it is.

Findings suggest potential screening and disease detection opportunities.

Approximately one-third of the individuals had an intracranial response among those with central nervous system metastases.

For coinfected patients who first contract influenza A, replication of SARS-CoV-2 may be suppressed, even 1 week after clearance of influenza A.

Individuals vaccinated simultaneously with COVID-19 booster and influenza vaccines may be more likely to experience systemic reactions and adverse health impacts.

New state law allows dispensation of HIV meds, distribution of fentanyl test strips starting in 2023.

There are many changes that need to be made on multiple levels of healthcare to combat health disparities and equity.

Dronabinol (Syndros) is a cannabinoid indicated in adults for the treatment of: anorexia associated with weight loss in patients with AIDS and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.

TriDerma Eczema Fast Healing helps sooth dry and irritated skin for itch relief.

Analysis shows that the common infection may be a driver of the disease in adults younger than aged 50 years.

Elecsys HCV Duo allows independent and simultaneous determination of early-stage infection and those who are recovering or showing signs of a chronic problem.

PSAO supports community pharmacies through patient access by unlocking the right payer agreements.

At the end of the day, we're interdisciplinary in terms of how it is that we need to manage our patients.

Treatment with faricimab-svoa (Vabysmo) may improve vision with fewer injections and treatment sessions for patients with wet age-related macular degeneration compared to other treatments.

Dupilumab (Dupixent) is the first medicine to improve signs of eosinophilic esophagitis and support weight gain in children ages 1 to 11, for whom there are no currently approved treatments.

What we're seeing as a trend is this significant increase in synthetic opioids, specifically fentanyl, being contaminated and causing severe overdoses.

Donald Miller, PharmD, discussed how the recent Supreme Court decision overturning Roe v. Wade has created confusion around access to methotrexate for patients in some states that are limiting abortion access.

Pharmacies and pharmacists are increasingly utilized for point-of-care (POC) services, including testing for infections that can be diagnosed via rapid testing.

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how pharmacy technicians can manage their own stress and burnout.

This inflammation of the colon poses a substantial burden to patients and the health care system.

Lumryz (FT218) treats cataplexy and excessive daytime sleepiness caused by narcolepsy.